-
Affiliation
-
Faculty of Pharmacy, Department of Pharmacy 病態生理学講座 (Shiba-Kyoritsu)
-
Position
-
Research Associate/Assistant Professor/Instructor
![]() KEIO RESEARCHERS INFORMATION SYSTEM |
Details of a Researcher
このページはJavascriptを使用しています。すべての機能を使用するためにはJavascript を有効にする必要があります。
Ichikawa, Daiju
|
|
GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase
Mikio Okayama, Kota Fujimori, Mariko Sato, Koichi Samata, Koki Kurita, Hiromu Sugiyama, Yutaka Suto, Genji Iwasaki, Taketo Yamada, Fumiyuki Kiuchi, Daiju Ichikawa, Maiko Matsushita, Maki Hirao, Hisako Kunieda, Kohei Yamazaki, Yutaka Hattori
Cancer Med . 12 ( 8 ) 9749 - 9759 2023.04
Research paper (scientific journal), Joint Work, Accepted
Nagase K., Okada A., Matsuda J., Ichikawa D., Hattori Y., Kanazawa H.
Colloids and Surfaces B: Biointerfaces (Colloids and Surfaces B: Biointerfaces) 220 2022.12
ISSN 09277765
PAX5-positive plasma cell leukemia presenting as lymphocytosis
Suzuka Tateno, Maki Hirao, Takahide Kikuchi, Yuiko Tsukada, Hisako Kunieda, Makoto Osada, Kohei Yamazaki, Ryunosuke Denda, Shigemichi Hirose, Maiko Matsushita, Daiju Ichikawa, Yutaka Hattori
Rinsho Ketsueki 63 ( 10 ) 1415 - 1420 2022
Research paper (scientific journal)
Thermally-modulated cell separation columns using a thermoresponsive block copolymer brush as a packing material for the purification of mesenchymal stem cells
Kenichi Nagase , Goro Edatsune, Yuki Nagata, Junnosuke Matsudo, Daiju Ichikawa, Sota Yamada, Yutaka Hattori, Hideko Kanazawa
Biomater Sci. 9 ( 21 ) 7054 - 7064 2021.10
Research paper (scientific journal), Accepted
Moriwaki Y., Kubo N., Watanabe M., Asano S., Shinoda T., Sugino T., Ichikawa D., Tsuji S., Kato F., Misawa H.
Scientific Reports (Scientific Reports) 10 ( 1 ) 2020.12
Research paper (scientific journal), Accepted
Development of a treatment for refractory hematologic malignancy by targeting epigenomic regulation
Ichikawa, Daiju
学事振興資金研究成果実績報告書 (慶應義塾大学) 2022
Overcoming resistance to new drug in hematological malignancy targeting LncRNA.
Ichikawa, Daiju
科学研究費補助金研究成果報告書 2021
Elucidating the molecular mechanism of IMiDs resistance in relapsed/refractory multiple myeloma.
Ichikawa, Daiju
学事振興資金研究成果実績報告書 (慶應義塾大学) 2020
Overcoming resistance to new drug, lenalidomide, in hematological malignancy targeting LncRNA
Ichikawa, Daiju
学事振興資金研究成果実績報告書 (慶應義塾大学) 2018
A challenge to overcome IMiDs resistance in hematological malignancies.
Ichikawa, Daiju
学事振興資金研究成果実績報告書 (慶應義塾大学) 2017
Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells
Hattori Y., Futo T., Uozaki R., Ichikawa D., Yamaguchi T., Yamamoto T., Matsushita M., Hirao M.
International Journal of Hematology (International Journal of Hematology) 115 ( 4 ) 605 - 608 2022.04
ISSN 09255710
E3 ubiquitin ligase in T cell anergy
ICHIKAWA Daiju
臨床免疫・アレルギー科 (科学評論社) 62 ( 4 ) 411 - 417 2014.10
Article, review, commentary, editorial, etc. (scientific journal), ISSN 1881-1930
慢性骨髄性白血病における新たな無治療寛解維持予測因子としてのミトコンドリアDNAコピー数の検討
鈴木未央, 飯島和香奈, 市川大樹, 山崎理絵, 櫻井政寿, 片山圭亮, 岡本真一郎, 服部豊, 松下麻衣子
第86回日本血液学会学術集会 (京都) ,
Poster presentation
松下麻衣子,栗田昂希,藤浪太晴,須藤豊,市川大樹,服部豊
第21回日本免疫治療学会学術集会,
Poster presentation
Epigenetic factor CDYL2 attenuates lenalidomide snsitivity in multiple myeloma
Daiju Ichikawa, Yuna Kamioka, Maiko Mastushita, Yutaka Hattori
第48回日本骨髄腫学会学術集会 (東京, 日本) ,
Poster presentation
Investigating the safety and efficacy of natural products that induce immunogenic cell death in multiple myeloma
藤浪太晴, 栗田昴希, 松下麻衣子, 市川大樹, 須藤豊, 服部豊
第48回日本骨髄腫学会学術集会 (東京, 日本) ,
Oral presentation (general)
Epigenetic factor CDYL2 is associated with lenalidomide-resistance in multiple myeloma
市川 大樹, 松下 麻衣子, 服部 豊
日本薬学会 第143年会 (北海道札幌市) ,
Poster presentation, 日本薬学会
エピゲノム制御による薬剤抵抗性難治性造血器腫瘍の克服
MEXT,JSPS, Grant-in-Aid for Scientific Research, 基盤研究(C), Principal investigator
Overcoming resistance to new drug in hematological malignancy tageting LncRNA.
MEXT,JSPS, Grant-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Principal investigator
Identification of novel therapeutic target molecules and the molecular mechanism for refractory multiple myeloma
MEXT,JSPS, Grant-in-Aid for Scientific Research, Grant-in-Aid for Young Scientists (B), Principal investigator
優秀ポスター演題賞
市川大樹, 2023.05, 第48回日本骨髄腫学会学術集会, Epigenetic factor CDYL2 attenuates lenalidomide sensitivity in multiple myeloma
Type of Award: International academic award (Japan or overseas)
CLINICAL IMMUNOLOGY
2024
BACHELOR'S THESIS
2024
ADVANCED PHARMACOTHERAPY
2024
ADVANCED MOLECULAR BIOLOGY OF DISEASE
2024
DISEASES AND PHARMACOTHERAPY 1 (LABORATORY MEDICINE)
2024